Skip to main content

Table 2 Plasma concentration of total aminothiols (glutathione, homocysteine, cysteine and cysteinylglycine) at baseline and after the 28-day treatment with fenofibrate or placebo

From: Treatment of chronic hemodialysis patients with low-dose fenofibrate effectively reduces plasma lipids and affects plasma redox status

Parameter Healthy controls* Baseline After Placebo After Fenofibrate
Glutathione [nmol/mL] 11.9 ± 4.9 5.6 ± 1.4 5.6 ± 1.6 6.5 ± 1.7#
Homocysteine [nmol/mL] 11.3 ± 3.2 24.2 ± 12.0 26.9 ± 13.1 29.4 ± 20.2##
Cysteine [nmol/mL] 275 ± 99 535 ± 105 552 ± 107 542 ± 106
Cysteinylglycine [nmol/ml] 25 ± 7 58 ± 12 56 ± 10 56 ± 14
  1. * healthy controls – historic cohort from Bald E et al. [19]
  2. # p = 0.02 vs baseline; ## p = 0.04 vs baseline